SIC vs HPLC
As a separation technique, it is claimed that sequential injection chromatography (SIC) has a number of advantages over HPLC, but also suffers from some limitations.
As a separation technique, it is claimed that sequential injection chromatography (SIC) has a number of advantages over HPLC, but also suffers from some limitations. A new study claims to have overcome these limitations, offering a method that is faster, more sensitive and uses less reagent than HPLC methods.1
The joint use of sequential injection analysis and monolithic columns facilitated SIC, which claims advantages over HPLC regarding simplicity, inexpensiveness, portability, ease-of-use, maintenance requirement and operation time. Unlike HPLC, SIC applies a miniaturized discontinuous flow-based procedure, therefore it is reported to be more reagent-saving than HPLC, rendering SIC methods inexpensive, as well as providing better safety for the environment. However, SIC does suffer from a number of drawbacks; it has a limited pressure tolerance, which causes solution leakage when applying high flow-rates, adopting a mobile phase including a buffer or installing long monolithic columns.
The new study has overcome some of the limitations with a new SIC assembly and method. By installing a valve with a higher pressure tolerance and additional ports the system avoided the problem of solution leakage. The SIC method was reported to offer advantages over the HPLC methods with respect to rapidity, reagent consumption and safety for the environment, besides the other benefits of the instrumentation of SIC over HPLC.
1. A.M. Idris and R.E.E. Elgorashe, Chemistry Central Journal, 5(28) (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
